Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta Protein”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02474251
What this trial is testing

Brain Sleep Clearance of Amyloid-Beta Peptides

Who this might be right for
Obstructive Sleep ApneaAlzheimer's Disease
NYU Langone Health 38
Not applicableStudy completedNCT02063217
What this trial is testing

Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction

Who this might be right for
Amyloid-beta
Washington University School of Medicine 36
Early research (Phase 1)Not Yet RecruitingNCT07142278
What this trial is testing

DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau

Who this might be right for
Alzheimer DiseaseAlzheimer Disease (AD)Preclinical Alzheimer's Disease
Nuravax, Inc. 24
Early research (Phase 1)Study completedNCT01978548
What this trial is testing

Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 45
Not applicableStudy completedNCT07294586
What this trial is testing

Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaNeurodegenerative Disorders+5 more
Amoneta Diagnostics SAS 200
Not applicableEnded earlyNCT05820932
What this trial is testing

Predicting Cognitive Decline From Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
University of California, San Francisco 32
Not applicableStudy completedNCT02959489
What this trial is testing

Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)

Who this might be right for
Alzheimer DiseaseAmyloid Beta-PeptidesRisk Assessment+3 more
Brigham and Women's Hospital 315
Not applicableStudy completedNCT01425957
What this trial is testing

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

Who this might be right for
MILD COGNITIVE IMPAIRMENT
Qualissima 229
Early research (Phase 1)Study completedNCT00439010
What this trial is testing

Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects

Who this might be right for
Alzheimers Disease
Molecular NeuroImaging 30
Early research (Phase 1)Ended earlyNCT00605059
What this trial is testing

Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 3
Not applicableStudy completedNCT02129452
What this trial is testing

Olfactory Neuroepithelial Tissue of Alzheimer Disease

Who this might be right for
Alzheimer Disease
Seoul National University Hospital 40
Post-approval studies (Phase 4)Study completedNCT00046358
What this trial is testing

The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute of Mental Health (NIMH) 50
Early research (Phase 1)Ended earlyNCT00544453
What this trial is testing

Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC

Who this might be right for
Alzheimer Disease
Molecular NeuroImaging 2
Post-approval studies (Phase 4)Not Yet RecruitingNCT06911944
What this trial is testing

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Who this might be right for
Down Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease+1 more
Michael Rafii, MD, PhD 60
Large-scale testing (Phase 3)Study completedNCT01561053
What this trial is testing

Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 347
Early research (Phase 1)Study completedNCT00456417
What this trial is testing

Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimers Disease
Institute for Neurodegenerative Disorders 30
Early research (Phase 1)Study completedNCT02033668
What this trial is testing

Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 36
Not applicableUnknownNCT01819545
What this trial is testing

The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 300
Not applicableStudy completedNCT02770482
What this trial is testing

Amyloid Beta-peptide 1-40 and Alzheimer's Disease

Who this might be right for
Alzheimer Disease
CHU de Reims 204
Very early researchEnded earlyNCT01000870
What this trial is testing

Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 6
Next Page